The Brink’s Company:企業の戦略・SWOT・財務情報

◆英語タイトル:The Brink's Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3696
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Brink’s Company – Strategy, SWOT and Corporate Finance Report
Summary

The Brink’s Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Brink’s Company (Brink’s or “the company”) is a provider of secure logistics and security solutions, including cash-in-transit, ATM replenishment and maintenance, international transportation of valuables, cash management and payment services. The company serves financial institutions, retailers, government agencies (including central banks), mints, jewelers and other commercial operations around the world. The company operates in the US, Latin America, Europe, Middle East and Africa (EMEA) and Asia. Brink’s is headquartered in Richmond, Virginia, the US

Scope

- Detailed information on The Brink’s Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Brink’s Company in the form of a SWOT analysis
- An in-depth view of the business model of The Brink’s Company including a breakdown and examination of key business segments
- Intelligence on The Brink’s Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Brink’s Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Brink’s Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Brink’s Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Brink’s Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Brink’s Company: Company Overview 9
The Brink’s Company: Overview and Key Facts 9
The Brink’s Company: Overview 9
The Brink’s Company: Key Facts 9
The Brink’s Company: Key Employees 11
The Brink’s Company: Key Employee Biographies 12
The Brink’s Company: Major Products and Services 17
The Brink’s Company: Company History 18
The Brink’s Company: Management Statement 21
The Brink’s Company: Locations and Subsidiaries 24
The Brink’s Company: Key Competitors 25
The Brink’s Company: Company Analysis 26
The Brink’s Company: Business Description 26
The Brink’s Company: SWOT Analysis 28
The Brink’s Company: SWOT Overview 28
The Brink’s Company: Strengths 28
The Brink’s Company: Weaknesses 29
The Brink’s Company: Opportunities 29
The Brink’s Company: Threats 29
The Brink’s Company: Corporate Financial Deals Activity 31
The Brink’s Company: Financial Deals Overview 31
The Brink’s Company: Targets and Partners 33
The Brink’s Company: Top Deals 2014 – 2018YTD* 34
The Brink’s Company: Advisors 35
The Brink’s Company: Top Legal Advisors 35
The Brink’s Company: Top Financial Advisors 35
The Brink’s Company: Mergers and Acquisitions 36
The Brink’s Company: Recent Developments 37
The Brink’s Company: News and Events Summary 37
The Brink’s Company: Corporate Governance 39
The Brink’s Company: Financial Deals 40
The Brink’s Company: Financial Performance 40
Appendix 43
Contact Us 43
Methodology 43
About MarketLine 44

List of Tables
Table 1: The Brink's Company: Key Facts
Table 2: The Brink's Company: Key Employees
Table 3: The Brink's Company: Locations and Subsidiaries
Table 4: The Brink's Company: Key Competitors
Table 5: The Brink's Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Brink's Company: M&A Activity by Geography (TTM*)
Table 7: The Brink's Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: The Brink's Company: M&A Average Deal Size - Value (US$m)
Table 9: The Brink's Company: Targets and Partners
Table 10: The Brink's Company: Top Deals 2014 - 2018YTD*
Table 11: The Brink's Company: Legal Advisor Ranking by Value (US$m)
Table 12: The Brink's Company: Financial Advisor Ranking by Value (US$m)
Table 13: The Brink's Company: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: The Brink's Company: M&A Activity by Geography (2014 - YTD*2018)
Table 15: The Brink's Company: News and Events Summary
Table 16: The Brink's Company: Corporate Governance
Table 17: The Brink's Company: Financial Deals
Table 18: The Brink's Company: Financial Performance

List of Figures
Figure 1: The Brink's Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Brink's Company: M&A Activity by Geography (TTM*)
Figure 3: The Brink's Company: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: The Brink's Company: M&A Average Deal Size - Value (US$m)
Figure 5: The Brink's Company: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: The Brink's Company: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[The Brink’s Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Theratechnologies Inc (TH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theratechnologies Inc (Theratechnologies) is a pharmaceutical company that focuses on the discovery and development of drugs for metabolic disorders. The company develops therapeutic peptide products, with an emphasis on growth releasing factor (GRF) peptides. Its lead products include Egrif …
  • Boardriders, Inc:企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析
    Summary Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Ch …
  • Zeria Pharmaceutical Co Ltd (4559):製薬・医療:M&Aディール及び事業提携情報
    Summary Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd is a pharmaceutical company that manufactures pharmaceutical and non-pharmaceuticals, veterinary pharmaceuticals, industrial chemicals and reagents. The company imports and exports healthcare products such as cosmet …
  • Lantheus Medical Imaging Inc:企業の製品パイプライン分析2018
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • Juno Therapeutics Inc:企業の戦略的SWOT分析
    Juno Therapeutics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Camlin Fine Sciences Limited:戦略・SWOT・企業財務分析
    Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Flotek Industries Inc (FTK):企業の財務・戦略的SWOT分析
    Summary Flotek Industries Inc (Flotek) is a developer of chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, and coil tubing chemistry. Its sti …
  • Leclanche SA (LECN):電力:M&Aディール及び事業提携情報
    Summary Leclanche SA (Leclanche) is a custom battery storage solutions provider. The company develops and manufactures energy storage systems with large format lithium-ion cells. It also offers batteries and storage systems including portable energy systems, accumulators, torches and chargers. The c …
  • Chatham Lodging Trust:企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Manitou Bf Sa
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The McClatchy Company:企業の戦略・SWOT・財務情報
    The McClatchy Company - Strategy, SWOT and Corporate Finance Report Summary The McClatchy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the app …
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Biofrontera AG (B8F):医療機器:M&Aディール及び事業提携情報
    Summary Biofrontera AG (Biofrontera) is a biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics. The company’s products comprise Ameluz, BF-RhodoLED and Belixos. Its prescription drug Ameluz is used for the treatment of skin disease actinic kerat …
  • Vertex Pharmaceuticals Inc (VRTX):企業の財務・戦略的SWOT分析
    Vertex Pharmaceuticals Inc (VRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Royal DSM NV (DSM):電力:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆